Are you Dr. Borkar?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 16 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
840 Walnut St
Ste 1020
Philadelphia, PA 19107Phone+1 800-331-6634Fax+1 215-825-2443
Summary
- Dr. Durga Borkar, MD is a board certified ophthalmologist in Philadelphia, Pennsylvania. She is currently licensed to practice medicine in Pennsylvania, North Carolina, and Massachusetts. She is affiliated with Duke University Hospital.
Education & Training
Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolResidency, Ophthalmology, 2014 - 2017
St Elizabeth's Medical Center/Lemuel Shattuck HospitalInternship, Transitional Year, 2013 - 2014
Northwestern University The Feinberg School of MedicineClass of 2013
Certifications & Licensure
NC State Medical License 2019 - 2025
PA State Medical License 2017 - 2021
MA State Medical License 2013 - 2017- American Board of Ophthalmology Ophthalmology
- American Board of Preventive Medicine Clinical Informatics
Publications & Presentations
PubMed
- 54 citationsThe impact of prefilled syringes on endophthalmitis following intravitreal injection of ranibizumab.Philip Storey, Zujaja Tauqeer, Yoshihiro Yonekawa, Bozho Todorich, Jeremy D. Wolfe
American Journal of Ophthalmology. 2019-03-01 - 24 citationsEndophthalmitis Rates after Bilateral Same-Day Intravitreal Anti–Vascular Endothelial Growth Factor InjectionsDurga S. Borkar, Anthony Obeid, Daniel C. Su, Philip Storey, Xinxiao Gao
American Journal of Ophthalmology. 2018-10-01 - 13 citationsEndophthalmitis Rates and Clinical Outcomes Following Penetrating and Endothelial Keratoplasty.Durga S Borkar, Turner D Wibbelsman, Preema M Buch, Sara B Rapuano, Anthony Obeid
American Journal of Ophthalmology. 2019-09-01
Press Mentions
Diabetic Vitreous Hemorrhage: Inject or Operate?September 3rd, 2024- Verana Health to Present Findings of Diabetic Retinopathy Study Using American Academy of Ophthalmology IRIS® Registry Data at AMIA Annual SymposiumNovember 7th, 2022
- Verana Health to Present Findings of Studies Using American Academy of Ophthalmology IRIS® Registry Data to Advance Insights into Real World Outcomes in Treating AMDNovember 2nd, 2022
